Hébert, Sébastien S.

Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., & De Strooper, B. (2008) · Proceedings of the National Academy of Sciences

Alzheimer's disease research and treatmentsMicroRNA in disease regulation

Cited by 1,183

Alterations of the microRNA network cause neurodegenerative disease

Hébert, S. S., & De Strooper, B. (2009) · Trends in Neurosciences

MicroRNA in disease regulationNeuroinflammation and Neurodegeneration Mechanisms

Cited by 452

MicroRNA regulation of Alzheimer's Amyloid precursor protein expression

Hébert, S. S., Horré, K., Nicolaï, L., Bergmans, B., Papadopoulou, A. S., Delacourte, A., & De Strooper, B. (2009) · Neurobiology of Disease

Alzheimer's disease research and treatmentsMicroRNA in disease regulation

Cited by 436

The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases

Finnerty, J. R., Wang, W.-X., Hébert, S. S., Wilfred, B. R., Mao, G., & Nelson, P. T. (2010) · Journal of Molecular Biology

MicroRNA in disease regulationPlant Molecular Biology Research

Cited by 371

MicroRNAs in Alzheimer's disease

Delay, C., Mandemakers, W., & Hébert, S. S. (2012) · Neurobiology of Disease

MicroRNA in disease regulationAlzheimer's disease research and treatments

Cited by 185

Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer’s Disease

Liu, D., Tang, H., Li, X.-Y., Deng, M.-F., Wei, N., Wang, X., Zhou, Y.-F., Wang, D.-Q., Fu, P., Wang, J.-Z., et al. (2017) · Molecular Therapy

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 127

A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer’s disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls

Hébert, S. S., Wang, W.-X., Zhu, Q., & Nelson, P. T. (2013) · Journal of Alzheimer's Disease

MicroRNA in disease regulationAlzheimer's disease research and treatments

Cited by 125

Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington’s disease

Gratuze, M., Noël, A., Julien, C., Cisbani, G., Milot-Rousseau, P., Morin, F., Dickler, M., Goupil, C., Bezeau, F., Poitras, I., et al. (2015) · Human Molecular Genetics

Genetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

Cited by 65

Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner

Eysert, F., Coulon, A., Boscher, E., Vreulx, A.-C., Flaig, A., Mendes, T., Hughes, S., Grenier-Boley, B., Hanoulle, X., Demiautte, F., et al. (2021) · Molecular Psychiatry

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 55